**Author details**

Matthew Martin1 , Antja-Voy Hartley1 , Jiamin Jin1 , Mengyao Sun1 and Tao Lu1,2,3\*

1 Department of Pharmacology and Toxicology, Indiana University School of Medicine, USA

2 Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, USA

3 Department of Medical and Molecular Genetics, Indiana University School of Medicine, USA

\*Address all correspondence to: lut@iu.edu

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**57**

jbc-M116

2015;**6**(30):29396

*Phosphorylation of NF-κB in Cancer*

[1] Jost PJ, Ruland J. Aberrant NF-κB signaling in lymphoma: Mechanisms, consequences, and therapeutic implications. Blood.

2007;**109**(7):2700-2707

Oncotarget. 2011;**2**(8):646

Cell. 1986;**46**(5):705-716

2015;**75**(18):3692-3695

2013;**91**(9):1029-1037

2014;**2**(9):823-830

2010;**321**(1):29-35

2011;**43**(11):1537-1549

[9] Martin M et al. Novel serine 176 phosphorylation of YBX1 activates NF-κB in colon cancer. Journal of Biological Chemistry. 2017.

[10] Prabhu L et al. Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer. Oncotarget.

[3] Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

[4] Lu T, Stark GR. NF-κB: Regulation by methylation. Cancer Research.

[5] Vaiopoulos AG, Athanasoula KC, Papavassiliou AG. NF-κB in colorectal cancer. Journal of Molecular Medicine.

[6] Xia Y, Shen S, Verma IM. NF-κB, an active player in human cancers. Cancer Immunology Research.

[7] Pacifico F, Leonardi A. Role of NF-κB in thyroid cancer. Molecular and Cellular Endocrinology.

[8] Morais C et al. The emerging role of nuclear factor kappa B in renal cell carcinoma. The International Journal of Biochemistry & Cell Biology.

**References**

*DOI: http://dx.doi.org/10.5772/intechopen.83650*

[11] Prabhu L et al. Critical role of NF-κB in pancreatic cancer. Oncotarget.

[12] Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: The roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Advances in Immunology. 2006;**90**:1-50

[13] Hinz M et al. NF-κB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Molecular and Cellular Biology. 1999;**19**(4):2690-2698

[14] Wu Y et al. Stabilization of snail by NF-κB is required for inflammationinduced cell migration and invasion. Cancer Cell. 2009;**15**(5):416-428

[15] Gasparini C et al. NF-κB pathways in hematological malignancies. Cellular and Molecular Life Sciences.

[16] Viatour P et al. Phosphorylation of NF-κB and IκB proteins: Implications in cancer and inflammation. Trends in Biochemical Sciences. 2005;**30**(1):43-52

[18] Wang Y-P et al. Astrocyte elevated gene-1 is associated with metastasis in head and neck squamous cell carcinoma through p65 phosphorylation and upregulation of MMP1. Molecular

[17] Hu J et al. Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-κB activation and transformation in resistant JB6 cells. Carcinogenesis.

2004;**25**(10):1991-2003

Cancer. 2013;**12**(1):109

[19] Zhang L et al. Function of phosphorylation of NF-kB p65 ser536 in prostate cancer oncogenesis.

Oncotarget. 2015;**6**(8):6281

2014;**71**(11):2083-2102

2014;**5**(22):10969

[2] Nogueira L et al. The NFκB pathway: A therapeutic target in glioblastoma.
